|
Atrial Fibrillation Global Clinical Trials Review, H1, 2012
|
|||||||||||
| Preis** (Lieferformat): |
Versandkostenfrei ** WICHTIG: Alle Preise sind netto ausgewiesen. Abhängig von Versand- und Leistungsort ist hierauf noch USt. zu entrichten (Deutschland z.Z. 19%). Der korrekte Gesamtendpreis wird Ihnen mit der Angabe Ihrer Rechnungsadresse, USt-ID-Nr. etc. im Bestellverlauf ausgewiesen. Weitere Informationen zu den Bestandteilen des Kaufpreises finden Sie in unseren FAQs. |
Zahlen und Fakten zur Studie: | 131 seiten | |||||||||
| Inhalt der Studie: |
Introduction
GlobalData's clinical trial report, “Atrial Fibrillation Global Clinical Trials Review, H1, 2012" provides data on the Atrial Fibrillation clinical trial scenario. This report provides e.....
Introduction GlobalData's clinical trial report, “Atrial Fibrillation Global Clinical Trials Review, H1, 2012" provides data on the Atrial Fibrillation clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Atrial Fibrillation. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Atrial Fibrillation. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type - Listings of discontinued trials (suspended, withdrawn and terminated) Highlights Reasons to buy - Understand the dynamics of a particular indication in a condensed manner - Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more - Obtain discontinued trial listing for trials across the globe - Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies [Studien Infos ausblenden] |
|||||||||||
|
Table of Contents Table of Contents 2 List of Tables 5 List of Figures 6 Introduction 7 Atrial Fibrillation 7 Report Guidance 7 Clinical Trials by Region 8 Clinical Trials by Country 9 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11 Top Five Countries Contributing to Clinical Trials in Europe 12 Top Countries Contributing to Clinical Trials in North America 13 Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14 Top Five Countries Contributing to Clinical Trials in Central and South America 15 Clinical Trials by BRIC Nations 16 Clinical Trials by G7 Nations 17 Clinical Trials in G7 Nations by Trial Status 18 Clinical Trials by E7 Nations 19 Clinical Trials in E7 Nations by Trial Status 20 Clinical Trials by Phase 21 In Progress Trials by Phase 22 Clinical Trials by Trial Status 23 Unaccomplished Trials of Atrial Fibrillation 24 Subjects Recruited Over a Period of Time 29 Prominent Sponsors 30 Top Companies Participating in Atrial Fibrillation Therapeutics Clinical Trials 32 Prominent Drug Comparison 34 Clinical Trial Profiles 35 Clinical Trial Overview of Top Companies 35 St. Jude Medical, Inc. 35 Clinical Trial Overview of St. Jude Medical, Inc. 35 Sanofi 37 Clinical Trial Overview of Sanofi 37 Medtronic, Inc. 39 Clinical Trial Overview of Medtronic, Inc. 39 AstraZeneca PLC 40 Clinical Trial Overview of AstraZeneca PLC 40 Boehringer Ingelheim GmbH 41 Clinical Trial Overview of Boehringer Ingelheim GmbH 41 AtriCure, Inc. 42 Clinical Trial Overview of AtriCure, Inc. 42 Astellas Pharma Inc. 43 Clinical Trial Overview of Astellas Pharma Inc. 43 GlaxoSmithKline plc 44 Clinical Trial Overview of GlaxoSmithKline plc 44 Bristol-Myers Squibb Company 45 Clinical Trial Overview of Bristol-Myers Squibb Company 45 Daiichi Sankyo Company, Limited 46 Clinical Trial Overview of Daiichi Sankyo Company, Limited 46 Biosense Webster EMEA 47 Clinical Trial Overview of Biosense Webster EMEA 47 CardioFocus, Inc. 48 Clinical Trial Overview of CardioFocus, Inc. 48 Merck & Co., Inc. 49 Clinical Trial Overview of Merck & Co., Inc. 49 Bayer AG 50 Clinical Trial Overview of Bayer AG 50 Abbott Laboratories 51 Clinical Trial Overview of Abbott Laboratories 51 Atritech, Inc. 52 Clinical Trial Overview of Atritech, Inc. 52 Biotronik SE & Co. KG 53 Clinical Trial Overview of Biotronik SE & Co. KG 53 Biosense Webster, Inc. 54 Clinical Trial Overview of Biosense Webster, Inc. 54 Boston Scientific Corporation 55 Clinical Trial Overview of Boston Scientific Corporation 55 Pfizer Inc. 56 Clinical Trial Overview of Pfizer Inc. 56 Clinical Trial Overview of Top Universities / Institutes / Hospitals 57 Deutsches Herzzentrum Munchen 57 Clinical Trial Overview of Deutsches Herzzentrum Munchen 57 Mayo Clinic 58 Clinical Trial Overview of Mayo Clinic 58 University of Pennsylvania 59 Clinical Trial Overview of University of Pennsylvania 59 Emory University 60 Clinical Trial Overview of Emory University 60 Medtronic Bakken Research Center 61 Clinical Trial Overview of Medtronic Bakken Research Center 61 University of Pittsburgh 62 Clinical Trial Overview of University of Pittsburgh 62 The Cleveland Clinic 63 Clinical Trial Overview of The Cleveland Clinic 63 University Medical Center Groningen 64 Clinical Trial Overview of University Medical Center Groningen 64 Hospital Clinic de Barcelona 65 Clinical Trial Overview of Hospital Clinic de Barcelona 65 University of Calgary 66 Clinical Trial Overview of University of Calgary 66 Norwegian University of Science and Technology 67 Clinical Trial Overview of Norwegian University of Science and Technology 67 Vanderbilt University 68 Clinical Trial Overview of Vanderbilt University 68 Rigshospitalet 69 Clinical Trial Overview of Rigshospitalet 69 Medical University of Vienna 70 Clinical Trial Overview of Medical University of Vienna 70 Kuopio University Hospital 71 Clinical Trial Overview of Kuopio University Hospital 71 Creighton University 72 Clinical Trial Overview of Creighton University 72 Montreal Heart Institute Research Centre 73 Clinical Trial Overview of Montreal Heart Institute Research Centre 73 Eastbourne District General Hospital 74 Clinical Trial Overview of Eastbourne District General Hospital 74 Barts and The London NHS Trust 75 Clinical Trial Overview of Barts and The London NHS Trust 75 Brigham and Women's Hospital 76 Clinical Trial Overview of Brigham and Women's Hospital 76 Five Key Clinical Profiles 77 Appendix 128 Abbreviations 128 Definitions 128 Research Methodology 129 Secondary Research 129 About GlobalData 130 Contact Us 130 Disclaimer 130 Source 131 [Inhaltsverzeichnis ausblenden] |
||||||||||||
|
List of Tables Atrial Fibrillation Therapeutics Market, Global, Clinical Trials by Zone, 2012* 8 Atrial Fibrillation Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 9 Atrial Fibrillation Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 10 Atrial Fibrillation Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012* 11 Atrial Fibrillation Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 12 Atrial Fibrillation Therapeutics Clinical Trials, North America, Top Countries, 2012* 13 Atrial Fibrillation Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2012* 14 Atrial Fibrillation Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2012* 15 Atrial Fibrillation Therapeutics Clinical Trials, BRIC Countries, 2012* 16 Atrial Fibrillation Therapeutics Clinical Trials, G7 Countries, 2012* 17 Atrial Fibrillation Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 18 Atrial Fibrillation Therapeutics Clinical Trials, E7 Countries, 2012* 19 Atrial Fibrillation Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 20 Atrial Fibrillation Therapeutics Market, Global, Clinical Trials by Phase, 2012* 21 Atrial Fibrillation Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 22 Atrial Fibrillation Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 23 Atrial Fibrillation Therapeutics Market, Global, Suspended Clinical Trials, 2012* 24 Atrial Fibrillation Therapeutics Market, Global, Withdrawn Clinical Trials, 2012* 25 Atrial Fibrillation Therapeutics Market, Global, Terminated Clinical Trials, 2012* 26 Atrial Fibrillation Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 29 Atrial Fibrillation Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 31 Atrial Fibrillation Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 33 Atrial Fibrillation Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 34 Atrial Fibrillation Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Jude Medical, Inc., 2012* 35 Atrial Fibrillation Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2012* 37 Atrial Fibrillation Therapeutics Clinical Trials Market, Global, Clinical Trials by Medtronic, Inc., 2012* 39 Atrial Fibrillation Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2012* 40 Atrial Fibrillation Therapeutics Clinical Trials Market, Global, Clinical Trials by Boehringer Ingelheim GmbH, 2012* 41 Atrial Fibrillation Therapeutics Clinical Trials Market, Global, Clinical Trials by AtriCure, Inc., 2012* 42 Atrial Fibrillation Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2012* 43 Atrial Fibrillation Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2012* 44 Atrial Fibrillation Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2012* 45 Atrial Fibrillation Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2012* 46 Atrial Fibrillation Therapeutics Clinical Trials Market, Global, Clinical Trials by Biosense Webster EMEA, 2012* 47 Atrial Fibrillation Therapeutics Clinical Trials Market, Global, Clinical Trials by CardioFocus, Inc., 2012* 48 Atrial Fibrillation Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2012* 49 Atrial Fibrillation Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2012* 50 Atrial Fibrillation Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2012* 51 Atrial Fibrillation Therapeutics Clinical Trials Market, Global, Clinical Trials by Atritech, Inc., 2012* 52 Atrial Fibrillation Therapeutics Clinical Trials Market, Global, Clinical Trials by Biotronik SE & Co. KG, 2012* 53 Atrial Fibrillation Therapeutics Clinical Trials Market, Global, Clinical Trials by Biosense Webster, Inc., 2012* 54 Atrial Fibrillation Therapeutics Clinical Trials Market, Global, Clinical Trials by Boston Scientific Corporation, 2012* 55 Atrial Fibrillation Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012* 56 Atrial Fibrillation Therapeutics Clinical Trials Market, Global, Clinical Trials by Deutsches Herzzentrum Munchen, 2012* 57 Atrial Fibrillation Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2012* 58 Atrial Fibrillation Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pennsylvania, 2012* 59 Atrial Fibrillation Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2012* 60 Atrial Fibrillation Therapeutics Clinical Trials Market, Global, Clinical Trials by Medtronic Bakken Research Center, 2012* 61 Atrial Fibrillation Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2012* 62 Atrial Fibrillation Therapeutics Clinical Trials Market, Global, Clinical Trials by The Cleveland Clinic, 2012* 63 Atrial Fibrillation Therapeutics Clinical Trials Market, Global, Clinical Trials by University Medical Center Groningen, 2012* 64 Atrial Fibrillation Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Clinic de Barcelona, 2012* 65 Atrial Fibrillation Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Calgary, 2012* 66 Atrial Fibrillation Therapeutics Clinical Trials Market, Global, Clinical Trials by Norwegian University of Science and Technology, 2012* 67 Atrial Fibrillation Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2012* 68 Atrial Fibrillation Therapeutics Clinical Trials Market, Global, Clinical Trials by Rigshospitalet, 2012* 69 Atrial Fibrillation Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2012* 70 Atrial Fibrillation Therapeutics Clinical Trials Market, Global, Clinical Trials by Kuopio University Hospital, 2012* 71 Atrial Fibrillation Therapeutics Clinical Trials Market, Global, Clinical Trials by Creighton University, 2012* 72 Atrial Fibrillation Therapeutics Clinical Trials Market, Global, Clinical Trials by Montreal Heart Institute Research Centre, 2012* 73 Atrial Fibrillation Therapeutics Clinical Trials Market, Global, Clinical Trials by Eastbourne District General Hospital, 2012* 74 Atrial Fibrillation Therapeutics Clinical Trials Market, Global, Clinical Trials by Barts and The London NHS Trust, 2012* 75 Atrial Fibrillation Therapeutics Clinical Trials Market, Global, Clinical Trials by Brigham and Women's Hospital, 2012* 76 List of Figures Atrial Fibrillation Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 8 Atrial Fibrillation Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 9 Atrial Fibrillation Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 10 Atrial Fibrillation Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012* 11 Atrial Fibrillation Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 12 Atrial Fibrillation Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 13 Atrial Fibrillation Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2012* 14 Atrial Fibrillation Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2012* 15 Atrial Fibrillation Therapeutics Clinical Trials, BRIC Countries (%), 2012* 16 Atrial Fibrillation Therapeutics Clinical Trials, G7 Countries (%), 2012* 17 Atrial Fibrillation Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 18 Atrial Fibrillation Therapeutics Clinical Trials, E7 Countries (%), 2012* 19 Atrial Fibrillation Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 20 Atrial Fibrillation Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 21 Atrial Fibrillation Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 22 Atrial Fibrillation Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 23 Atrial Fibrillation Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 29 Atrial Fibrillation Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 30 Atrial Fibrillation Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 32 Atrial Fibrillation Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 34 GlobalData Methodology 129 [Tabellenverzeichnis ausblenden] |
||||||||||||
| Hinweis: | * Der Rechnungsbetrag für diese Studie wird in $ (Dollar) ausgewiesen. Kunden aus dem Inland bekommen von uns eine Rechnung in Euro, umgerechnet zum letztwöchigen Schlusskurs | |||||||||||
|
|
||||||||||||
